Company intelligence / Profile preview
Tonghua Anrate Biopharmaceutical Co., Ltd.
Tonghua, Jilin Province, Chinaanrate.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Completed Phase III clinical trials for recombinant human albumin injection, obtained drug production license
- Therapeutic areas
- GastroenterologyHematology
- Modalities
- Recombinant proteins
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Körber (strategic agreement signed in 2024)Dongbao Industry Group Co., Ltd.Indonesia (contract signed)Russia (completed on-site audits)
Beyond the preview
Go deeper on Tonghua Anrate Biopharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tonghua Anrate Biopharmaceutical Co., Ltd..